Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer

British Journal of Cancer

Volumn 111, Issue 8, 2014, Pages 1482-1489

  Hao, T B ^a   Shi, W ^a   Shen, X J ^a   Qi, J ^a   Wu, X H ^a   Wu, Y ^a   Tang, Y Y ^a   Ju, S Q ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PRIMER DNA; TUMOR MARKER;

BLOOD; CASE CONTROL STUDY; CELL FREE SYSTEM; COLORECTAL NEOPLASMS; HUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CASE-CONTROL STUDIES; CELL-FREE SYSTEM; COLORECTAL NEOPLASMS; DNA; DNA PRIMERS; HUMANS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84908672066     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.470     Document Type: Article

References (48)

1. Banki F, Mason RJ, Oh D, Hagen JA, DeMeester SR, Lipham JC, Tanaka K, Danenberg KD, Yacoub WN, Danenberg PV, DeMeester TR (2007) Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. Arch Surg 142: 533-538.
2. Brussel A, Sonigo P (2003) Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J Virol 77: 10119-10124.
3. Cardelli M (2011) Alu PCR. Methods Mol Biol 687: 221-229.
4. Chan KC, Leung SF, Yeung SW, Chan AT, Lo YM (2008) Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients. Clin Cancer Res 14: 4141-4145.
5. Chen H, Sun LY, Zheng HQ, Zhang QF, Jin XM (2012) Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma. Pathology 44: 318-324.
6. Chen K, Zhang H, Zhang LN, Ju SQ, Qi J, Huang DF, Li F, Wei Q, Zhang J (2013) Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma. World J Gastroenterol 19: 3143-3149.
7. Czeiger D, Shaked G, Eini H, Vered I, Belochitski O, Avriel A, Ariad S, Douvdevani A (2011) Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol 135: 264-270.
8. da Silva Filho BF, Gurgel AP, Neto MA, de Azevedo DA, de Freitas AC, Silva Neto Jda C, Silva LA (2013) Circulating cell-free DNA in serum as a biomarker of colorectal cancer. J Clin Pathol 66: 775-778.
9. Dagan T, Sorek R, Sharon E, Ast G, Graur D (2004) AluGene: a database of Alu elements incorporated within protein-coding genes. Nucleic Acids Res 32: D489-D492.
10. Diehl F, Schmidt K, Durkee KH, Moore KJ, Goodman SN, Shuber AP, Kinzler KW, Vogelstein B (2008) Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 135: 489-498.
11. Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A, Bastian PJ (2009) Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 181: 363-371.
12. Feng J, Gang F, Li X, Jin T, Houbao H, Yu C, Guorong L (2013) Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen. Int Urol Nephrol 45: 1023-1028.
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
14. Flamini E, Mercatali L, Nanni O, Calistri D, Nunziatini R, Zoli W, Rosetti P, Gardini N, Lattuneddu A, Verdecchia GM, Amadori D (2006) Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 12: 6985-6988.
15. Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47: 458-472.
16. Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S, Pierotti MA (2006) Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann NY Acad Sci 1075: 185-190.
17. Fujimoto A, O'Day SJ, Taback B, Elashoff D, Hoon DS (2004) Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome. Cancer Res 64: 4085-4088.
18. Gang F, Guorong L, An Z, Anne GP, Christian G, Jacques T (2010) Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum. Urology 75: 262-265.
19. Gao YJ, He YJ, Yang ZL, Shao HY, Zuo Y, Bai Y, Chen H, Chen XC, Qin FX, Tan S, Wang J, Wang L, Zhang L (2010) Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia. Clin Chem Lab Med 48: 1651-1656.
20. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD (1998) Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17: 89-97.
21. Hanley R, Rieger-Christ KM, Canes D, Emara NR, Shuber AP, Boynton KA, Libertino JA, Summerhayes IC (2006) DNA integrity assay: a plasmabased screening tool for the detection of prostate cancer. Clin Cancer Res 12: 4569-4574.
22. Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, VON Ruecker A, Müller SC, Bastian PJ (2010) Cell-free circulating DNA: diagnostic value in patients with renal cell cancer. Anticancer Res 30: 2785-2789.
23. Hohaus S, Giachelia M, Massini G, Mansueto G, Vannata B, Bozzoli V, Criscuolo M, D'Alò F, Martini M, Larocca LM, Voso MT, Leone G (2009) Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. Ann Oncol 20: 1408-1413.
24. Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P (2008) DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann NY Acad Sci 1137: 162-170.
25. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665.
26. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
27. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W, Sidransky D, Califano J (2006) Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer 119: 2673-2676.
28. Keesee SK, Briggman JV, Thill G, Wu YJ (1996) Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 6: 189-214.
29. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650.
30. Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856.
31. Mead R, Duku M, Bhandari P, Cree IA (2011) Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer 105: 239-245.
32. Mutch MG (2007) Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol 96: 693-703.
33. Nakas CT, Alonzo TA, Yiannoutsos CT (2010) Accuracy and cut-off point selection in three-class classification problems using a generalization of the Youden index. Stat Med 29: 2946-2955.
34. Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R (2009) Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 64: 92-97.
35. Pan S, Gu B, Wang H, Yan Z, Wang P, Pei H, Xie W, Chen D, Liu G (2013) Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis. J Thorac Dis 5(3): 251-257.
36. Pinzani P, Salvianti F, Zaccara S, Massi D, De Giorgi V, Pazzagli M, Orlando C (2011) Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. Clin Chim Acta 412: 2141-2145.
37. Qi J, Qian C, Shi W, Wu X, Jing R, Zhang L, Wang Z, Ju S (2013) Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Clin Biochem 46: 64-69.
38. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U (2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908.
39. Sriram KB, Relan V, Clarke BE, Duhig EE, Windsor MN, Matar KS, Naidoo R, Passmore L, McCaul E, Courtney D, Yang IA, Bowman RV, Fong KM (2012) Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer 12: 428.
40. Taback B, Hoon DS (2004a) Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann NY Acad Sci 1022: 1-8.
41. Taback B, Hoon DS (2004b) Circulating nucleic acids in plasma and serum: past, present and future. Curr Opin Mol Ther 6: 273-278.
42. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS (2006a) Prediction of breast tumour progression by integrity of free circulating DNA in serum. J Clin Oncol 24: 4270-4276.
43. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, Hoon DS (2006b) Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 52: 1062-1069.
44. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IM (2003) Increased plasma DNA integrity in cancer patients. Cancer Res 63: 3966-3968.
45. Yin J, Tian L (2014) Joint confidence region estimation for area under ROC curve and Youden index. Stat Med 33: 985-1000.
46. Zachariah RR, Schmid S, Buerki N, Radpour R, Holzgreve W, Zhong X (2008) Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumours. Obstet Gynecol 112: 843-850.
47. Zhong XY, Ladewig A, Schmid S, Wight E, Hahn S, Holzgreve W (2007) Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet 276: 327-331.
48. Zou H, Harrington JJ, Klatt KK, Ahlquist DA (2006) A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 15: 1115-1119.